Loading news...
Nature's Sunshine is upgraded to Buy, driven by robust DTC growth and effective influencer marketing. NATR exceeded 2025 guidance with $480.1M revenue and $49.4M adjusted EBITDA, signaling operational outperformance. Guidance for 2026 targets $500–$515M revenue and $50–$54M EBITDA, supporting a $37.99 price target—56% above current levels.
Nature's Sunshine Products delivered Q4 results and 2026 guidance that exceeded analyst expectations, driving a post-market stock surge. NATR's revenue, profits, and adjusted profits all grew year-over-year, with notable strength in Europe and North America and robust cash holdings of $93.9 million. Management guides for 2026 revenue of $500–515 million and EBITDA of $50–54 million, with a long-term vision to reach $1 billion in revenue.
Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript
LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.
Three consumer stocks are drawing fresh analyst attention this week as earnings season approaches.
LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call.
Hillsdale Investment Management Inc. boosted its position in shares of Nature's Sunshine Products, Inc. (NASDAQ: NATR) by 107.9% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 170,804 shares of the company's stock after acquiring an additional 88,657 shares during the period.
Nature's Sunshine Products, Inc. (NASDAQ: NATR - Get Free Report) was the target of a large increase in short interest in January. As of January 30th, there was short interest totaling 194,850 shares, an increase of 21.7% from the January 15th total of 160,148 shares. Currently, 1.2% of the shares of the stock are sold short.
Consumer confidence has dipped to multi-year lows, yet the coming fiscal stimulus could support consumer spending on essentials. While macro conditions remain mixed, staples' relative stability and essential nature make them compelling considerations for diversified portfolios. Investors looking for defensive exposure can consider opportunities not just in large cap staple giants, but in niche and value-oriented names poised to benefit from macro trends.
LEHI, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy Worldwide, a division of Nature's Sunshine Products, today announced that Euromonitor International has named Pro-Argi-9+ the world's #1 l-arginine supplement,* reinforcing the product's growing global momentum and Synergy's leadership in the health and wellness space.
AWM Investment Company Inc. purchased a new position in shares of Nature's Sunshine Products, Inc. (NASDAQ: NATR) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 350,000 shares of the company's stock, valued at approximately $5,176,000. AWM Investment Company Inc. owned 1.98%
Mr. Fritz Brings Decades of Operational Excellence and Innovation to Support the Company's Global Supply Chain Mr. Fritz Brings Decades of Operational Excellence and Innovation to Support the Company's Global Supply Chain
Nature's Sunshine delivered strong Q3 2025 results, driven by robust growth in Asia and recurring autoship sales. NATR's international focus, especially in Asia and Europe, positions it for continued growth, though its MLM model may cause choppy performance. Despite a strong balance sheet, buybacks, and premium margins, NATR's current valuation reflects its strengths, and it trades at a premium to other MLMs.
Nature's Sunshine Products, Inc. ( NATR ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Nathan Brower - Executive VP, General Counsel & Secretary Kenneth Romanzi - CEO & Director Shane Jones - Executive VP of Finance, CFO & Treasurer Conference Call Participants Brian Holland - D.A. Davidson & Co., Research Division Presentation Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's financial results for the third quarter ended September 30, 2025.
Net Sales up 12% to $128.3 Million, GAAP EPS up 30% to $0.30Adjusted EBITDA up 42% to $15.2 MillionRaised Full-Year Outlook LEHI, Utah, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Summary vs.
LEHI, Utah, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, November 6, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2025. The Company will report its financial results in a press release prior to the conference call.
Mr. Romanzi Brings Extensive Leadership and Operational Experience at Prominent, Large-Scale Consumer Packaged Goods Companies and Proven Track Record of Driving Growth and Value Creation LEHI, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that its Board of Directors has appointed Kenneth Romanzi to succeed Terrence Moorehead as Chief Executive Officer. Mr. Romanzi will assume the role and become a member of the Nature's Sunshine Board of Directors on October 29, 2025.
LEHI, Utah, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the relaunch of its Power Line suite of products with the addition of the newly launched Power Balance supplement. The enhanced product line features four supplements designed to address the growing metabolic health challenges facing millions of people worldwide.
Nature's Sunshine is a leading U.S.-based herbal supplement manufacturer founded in 1972, operating a Multi-Level Marketing model. Nature's Sunshine (NATR) is trading at a 16.4x forward P/E, a premium compared to the peer average of 14.2x, and higher than companies like Herbalife (4.1x) and USANA (11.2x). The company's forward revenue growth of 2.8% and mixed EPS outlook do not justify the premium valuation, especially when compared to competitors like LifeVantage, which has a 26.6% CAGR EPS.
Nature's Sunshine (NATR) Q2 EPS Up 400%